TradingView
AlenCiken
13 Jul 2018 pukul 21.17
CLBS granted regenerative medicine advanced therapy by FDA
Pembelian
NASDAQ:CLBS
240
Deskripsi
⋅
13 Jul 2018 pukul 21.17
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina
caladrius.com/press-release/caladrius-receives-fda-regenerative-medicine-advanced-therapy-designation-for-cd34-cell-therapy-for-treating-refractory-angina/
Trend Analysis
Chart Patterns
Technical Indicators
Lebih lanjut